Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACTIVE SPECIFIC IMMUNOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 280 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mocellin, S; Wang, E; Marincola, FM
      Cytokines and immune response in the tumor microenvironment

      JOURNAL OF IMMUNOTHERAPY
    2. Lambert, LA; Gibson, GR; Maloney, M; Barth, RJ
      Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens

      JOURNAL OF IMMUNOTHERAPY
    3. Karanikas, V; Thynne, G; Mitchell, P; Ong, CS; Gunawardana, D; Blum, R; Pearson, J; Lodding, J; Pietersz, G; Broadbent, R; Tait, B; McKenzie, IFC
      Mannan mucin-1 peptide immunization: Influence of cyclophosphamide and theroute of injection

      JOURNAL OF IMMUNOTHERAPY
    4. Zeh, HJ; Stavely-O'Carroll, K; Choti, MA
      Vaccines for colorectal cancer

      TRENDS IN MOLECULAR MEDICINE
    5. Holmberg, LA; Sandmaier, BM
      Theratope((R)) vaccine (STn-KLH)

      EXPERT OPINION ON BIOLOGICAL THERAPY
    6. Matzku, S; Zoller, M
      Specific immunotherapy of cancer in elderly patients

      DRUGS & AGING
    7. Fagnoni, FF; Della Cuna, GR
      Immunotherapy: On the edge between experimental and clinical oncology

      JOURNAL OF CHEMOTHERAPY
    8. Bystryn, JC; Zeleniuch-Jacquotte, A; Oratz, R; Shapiro, RL; Harris, MN; Roses, DF
      Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine

      CLINICAL CANCER RESEARCH
    9. Habal, N; Gupta, RK; Bilchik, AJ; Yee, R; Leopoldo, Z; Ye, W; Elashoff, RM; Morton, DL
      CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer

      ANNALS OF SURGICAL ONCOLOGY
    10. Staib, L; Harel, W; Mitchell, MS
      Optimization of intracerebral tumour protection by active-specific immunization against murine melanoma B16/G3.12

      MELANOMA RESEARCH
    11. Armstrong, AC; Eaton, D; Ewing, JC
      Science, medicine, and the future - Cellular immunotherapy for cancer

      BRITISH MEDICAL JOURNAL
    12. Zhu, YH; Vogel, P
      Synthesis of a C-disaccharide analog of the Thomsen-Friedenreich (T) epitope

      SYNLETT
    13. Monzavi-Karbassi, B; Kieber-Emmons, T
      Current concepts in cancer vaccine strategies

      BIOTECHNIQUES
    14. Bonaccorsi, P; Ansel, JC; Armstrong, CA
      Management of high-risk melanoma

      DERMATOLOGIC CLINICS
    15. Li, J; Holmes, LM; Franek, KJ; Burgin, KE; Wagner, TE; Wei, Y
      Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    16. Nyhus, JK; Wolford, CC; Friece, CR; Nelson, MB; Sampsel, JW; Barbera-Guillem, E
      IgG-recognizing shed tumor-associated antigens can promote tumor invasion and metastasis

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    17. Moingeon, P
      Cancer vaccines

      VACCINE
    18. Wataya, H; Kamikawaji, N; Nakanishi, Y; Takayama, K; Hara, N; Sasazuki, T
      Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line

      HUMAN IMMUNOLOGY
    19. Rains, N; Cannan, RJ; Chen, WX; Stubbs, RS
      Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer

      HEPATO-GASTROENTEROLOGY
    20. Safa, MM; Foon, KA
      Adjuvant immunotherapy for melanoma, and colorectal cancers

      SEMINARS IN ONCOLOGY
    21. Seitz, O; Heinemann, I; Mattes, A; Waldmann, H
      Synthetic peptide conjugates - tailor-made probes for the biology of protein modification and protein processing

      TETRAHEDRON
    22. Risinskaya, NV; Fegeding, KV; Vasilenko, OV; Sudarikov, AB
      Expression of the cloned hemagglutinin-neuraminidase gene of the Newcastledisease virus in mouse myeloma cells

      MOLECULAR BIOLOGY
    23. Lo-Man, R; Vichier-Guerre, S; Bay, S; Deriaud, E; Cantacuzene, D; Leclerc, C
      Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope

      JOURNAL OF IMMUNOLOGY
    24. Berd, D; Sato, T; Cohn, H; Maguire, HC; Mastrangelo, MJ
      Treatment of metastatic melanoma with autologous, hapten-modified melanomavaccine: Regression of pulmonary metastases

      INTERNATIONAL JOURNAL OF CANCER
    25. Vogel, P
      Monosaccharide and disaccharide mimics: New molecular tools for biology and medicine

      CHIMIA
    26. Merkel, S; Wein, A; Gunther, K; Papadopoulos, T; Hohenberger, W; Hermanek, P
      High-risk groups of patients with stage II colon carcinoma

      CANCER
    27. Allen, JR; Harris, CR; Danishefsky, SJ
      Pursuit of optimal carbohydrate-based anticancer vaccines: Preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    28. Steiner, T; Schubert, J
      Systemic treatment of renal-cell carcinoma: present status

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    29. Li, Q; Normolle, DP; Sayre, DM; Zeng, XY; Sun, R; Jiang, GH; Redman, B; Chang, AE
      Immunological effects of BCG as an adjuvant in autologous tumor vaccines

      CLINICAL IMMUNOLOGY
    30. Danishefsky, SJ; Allen, JR
      From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    31. Vichier-Guerre, S; Lo-Man, R; Bay, S; Deriaud, E; Nakada, H; Leclerc, C; Cantacuzene, D
      Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen

      JOURNAL OF PEPTIDE RESEARCH
    32. Smith, ER; Chiocca, EA
      Oncolytic viruses as novel anticancer agents: turning one scourge against another

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    33. Newman, MJ
      Vaccines adjuvants

      EXPERT OPINION ON THERAPEUTIC PATENTS
    34. Park, JW; Tripathy, D; Campbell, MJ; Esserman, LJ
      Biological therapy of breast cancer

      BIODRUGS
    35. Royce, ME; Hoff, PM; Pazdur, R
      Progress in colorectal cancer chemotherapy - How far have we come, how farto go?

      DRUGS & AGING
    36. Jiang, XP; Yang, DC; Elliott, RL; Head, JF
      Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125 - Results in immune and clinical responses in breast cancer patients

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    37. Dillman, RO; Beutel, LD; Cornforth, AN; Nayak, SK
      Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    38. Brinckerhoff, LH; Thompson, LW; Slingluff, GL
      Melanoma vaccines

      CURRENT OPINION IN ONCOLOGY
    39. Bremers, AJA; Parmiani, G
      Immunology and immunotherapy of human cancer: present concepts and clinical developments

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    40. Sinkovics, JG; Horvath, JC
      Vaccination against human cancers

      INTERNATIONAL JOURNAL OF ONCOLOGY
    41. Allen, JR; Allen, JG; Zhang, XF; Williams, LJ; Zatorski, A; Ragupathi, G; Livingston, PO; Danishefsky, SJ
      A second generation synthesis of the MBr1 (Globo-H) breast tumor antigen: New application of the n-pentenyl glycoside method for achieving complex carbohydrate protein linkages

      CHEMISTRY-A EUROPEAN JOURNAL
    42. Fujii, S; Huang, S; Fong, TC; Ando, D; Burrows, F; Jolly, DJ; Nemunaitis, J; Hoon, DSB
      Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients

      CANCER GENE THERAPY
    43. Baars, A; Claessen, AME; van den Eertwegh, AJM; Gall, HE; Stam, AGM; Meijer, S; Giaccone, G; Meijer, CJLM; Scheper, RJ; Wagstaff, J; Vermorken, JB; Pinedo, HM
      Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients

      ANNALS OF ONCOLOGY
    44. Laheru, DA; Jaffee, EM
      Potential role of tumor vaccines in GI malignancies

      ONCOLOGY-NEW YORK
    45. Glinsky, GV; Ivanova, AB; Welsh, J; McClelland, M
      The role of blood group antigens in malignant progression, apoptosis resistance, and metastatic behavior

      TRANSFUSION MEDICINE REVIEWS
    46. Ben-Efraim, S; Bizzini, B; Relyveld, EH
      Use of xenogenized (modified) tumor cells for treatment in experimental tumor and in human neoplasia

      BIOMEDICINE & PHARMACOTHERAPY
    47. Bremers, AJA; Kuppen, PJK; Parmiani, G
      Tumour immunotherapy: the adjuvant treatment of the 21st century?

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    48. Mihich, E
      Historical overview of biologic response modifiers

      CANCER INVESTIGATION
    49. Spitler, LE; Grossbard, ML; Ernstoff, MS; Silver, G; Jacobs, M; Hayes, FA; Soong, SJ
      Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor

      JOURNAL OF CLINICAL ONCOLOGY
    50. Foon, KA; Lutzky, J; Baral, RN; Yannelli, JR; Hutchins, L; Teitelbaum, A; Kashala, OL; Das, R; Garrison, J; Reisfeld, RA; Bhattacharya-Chatterjee, M
      Clinical and immune responses in advanced melanoma patients immunized withan anti-idiotype antibody mimicking disialoganglioside GD2

      JOURNAL OF CLINICAL ONCOLOGY
    51. von Mensdorff-Pouilly, S; Snijdewint, FGM; Verstraeten, AA; Verheijen, RHM; Kenemans, P
      Human MUC1 mucin: a multifaceted glycoprotein

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    52. Bocchia, M; Bronte, V; Colombo, MP; De Vincentiis, A; Di Nicola, M; Forni, G; Lanata, L; Lemoli, RM; Massaia, M; Rondelli, D; Zanon, P; Tura, S
      Antitumor vaccination: where we stand

      HAEMATOLOGICA
    53. Perico, ME; Mezzanzanica, D; Luison, E; Alberti, P; Panza, L; Russo, G; Canevari, S
      Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    54. Montero, E; Amador, JF; Perez, R; Lage, A
      Tumor-specific immunotherapy based on dominant models of natural tolerance

      MEDICAL HYPOTHESES
    55. Yip, D; Strickland, AH; Karapetis, CS; Hawkins, CA; Harper, PG
      Immunomodulation therapy in colorectal carcinoma

      CANCER TREATMENT REVIEWS
    56. Rodenburg, CJ; Willemse, PHB; Mulder, NH
      Consensus conference on adjuvant and palliative treatment of colorectal cancer

      NETHERLANDS JOURNAL OF MEDICINE
    57. Goldman, Y; Shinitzky, M
      Immunotherapy of cancer with a pressurized, surface reduced tumor-cell vaccine

      DRUG DEVELOPMENT RESEARCH
    58. Holmberg, LA; Oparin, DV; Gooley, T; Lilleby, K; Bensinger, W; Reddish, MA; MacLean, GD; Longenecker, BM; Sandmaier, BM
      Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (R) STn-KLH cancer vaccine

      BONE MARROW TRANSPLANTATION
    59. Bodey, B; Bodey, B; Siegel, SE; Kaiser, HE
      Failure of cancer vaccines: The significant limitations of this approach to immunotherapy

      ANTICANCER RESEARCH
    60. Tallberg, TH; Uusitalo, R; Sarna, S; Seregard, S; Werschnik, C
      Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma

      ANTICANCER RESEARCH
    61. Curiel-Lewandrowski, C; Demierre, MF
      Advances in specific immunotherapy of malignant melanoma

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    62. Walsh, P; Gibbs, P; Gonzalez, R
      Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    63. Schadendorf, D; Paschen, A; Sun, YS
      Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma

      IMMUNOLOGY LETTERS
    64. Bleiberg, H
      Adjuvant therapy in high-risk colon cancer

      SEMINARS IN ONCOLOGY
    65. Vermorken, JB
      Adjuvant immunotherapy in colorectal cancer

      SEMINARS IN ONCOLOGY
    66. Schirrmacher, V
      Anti-tumor vaccination

      ZENTRALBLATT FUR CHIRURGIE
    67. Reeves, ME; Coit, DG
      Melanoma - A multidisciplinary approach for the general surgeon

      SURGICAL CLINICS OF NORTH AMERICA
    68. Wang, XH; Luo, W; Ferrone, S
      Inmunotherapy of melanoma: Peptide mimics of a human high molecular weight-melanoma associated antigen

      MEDICINA-BUENOS AIRES
    69. Maxwell-Armstrong, CA; Scholefield, JH
      Current perspectives on immunotherapy for colorectal cancer

      DRUGS OF TODAY
    70. Schwaab, T; Heaney, JA; Schned, AR; Harris, RD; Cole, BF; Noelle, RJ; Phillips, DM; Stempkowski, L; Ernstoff, MS
      A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha 2b therapy in patients with metastatic renal cell carcinoma: Clinical outcome and analysis of immunological parameters

      JOURNAL OF UROLOGY
    71. Chang, EY; Chen, CH; Ji, HX; Wang, TL; Hung, K; Lee, BP; Huang, AYC; Kurman, RJ; Pardoll, DM; Wu, TC
      Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine

      INTERNATIONAL JOURNAL OF CANCER
    72. Ragupathi, G; Meyers, M; Adluri, S; Howard, L; Musselli, C; Livingston, PO
      Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21

      INTERNATIONAL JOURNAL OF CANCER
    73. Mitchell, MS; Kan-Mitchell, J; Minev, B; Edman, C; Deans, RJ
      A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes

      CANCER RESEARCH
    74. Rigel, DS; Carucci, JA
      Malignant melanoma: Prevention, early detection, and treatment in the 21stCentury

      CA-A CANCER JOURNAL FOR CLINICIANS
    75. Dalgleish, AG
      Cancer vaccines

      BRITISH JOURNAL OF CANCER
    76. Woodlock, TJ; Sahasrabudhe, DM; Marquis, DM; Greene, D; Pandya, KJ; McCune, CS
      Active specific immunotherapy for metastatic colorectal carcinoma: Phase Istudy of an allogeneic cell vaccine plus low-dose interleukin-1 alpha

      JOURNAL OF IMMUNOTHERAPY
    77. Leong, SPL; Enders-Zohr, P; Zhou, YM; Stuntebeck, S; Habib, FA; Allen, RE; Sagebiel, RW; Glassberg, AB; Lowenberg, DW; Hayes, FA
      Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanoma

      JOURNAL OF IMMUNOTHERAPY
    78. Sandmaier, BM; Oparin, DV; Holmberg, LA; Reddish, MA; MacLean, GD; Longenecker, BM
      Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine

      JOURNAL OF IMMUNOTHERAPY
    79. Evans, TRJ; Kaye, SB
      Vaccine therapy for cancer - fact or fiction?

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    80. Scheele, J; Altendorf-Hofmann, A
      Resection of colorectal liver metastases

      LANGENBECKS ARCHIVES OF SURGERY
    81. Staib, L; Link, KH; Beger, HG
      Immunotherapy in pancreatic cancer - current status and future

      LANGENBECKS ARCHIVES OF SURGERY
    82. Cox, J; Coulter, A
      Prospects for the development of new vaccine adjuvants

      BIODRUGS
    83. DeMatos, P; Seigler, HF
      Monitoring antitumour immune response during immunotherapy of cancer - Whyand how?

      BIODRUGS
    84. McGee, JMC; Patten, MR; Malnar, KF; Price, JA; Mayes, JS; Watson, GH
      Comparison of melanoma antigens in whole tumor vaccine to those from IIB-MEL-J cells

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    85. Nayak, SK; Schiltz, PM; Dillman, RO
      Modulation of renal carcinoma cells in vitro: Comparison after transduction with retroviral vector containing a human IFN-gamma gene versus incubation with soluble IFN-gamma

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    86. Foon, KA; Yannelli, J; Bhattacharya-Chatterjee, M
      Colorectal cancer as a model for immunotherapy

      CLINICAL CANCER RESEARCH
    87. Morse, MA; Lyerly, HK
      Cellular and biological therapies of gastrointestinal tumors: Overview of clinical trials

      ANNALS OF SURGICAL ONCOLOGY
    88. Palmer, K; Moore, J; Everard, M; Harris, JD; Rodgers, S; Rees, RC; Murray, AK; Mascari, R; Kirkwood, J; Riches, PG; Fisher, C; Thomas, JM; Harries, M; Johnston, SRD; Collins, MKL; Gore, ME
      Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

      HUMAN GENE THERAPY
    89. Schreiber, S; Kampgen, E; Wagner, E; Pirkhammer, D; Trcka, J; Korschan, H; Lindemann, A; Dorffner, R; Kittler, H; Kasteliz, F; Kupcu, Z; Sinski, A; Zatloukal, K; Buschle, M; Schmidt, W; Birnstiel, M; Kempe, RE; Voigt, T; Weber, HA; Pehamberger, H; Mertelsmann, R; Brocker, EB; Wolff, K; Stingl, G
      Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2 transfected cancer cells: Outcome of a phase I study

      HUMAN GENE THERAPY
    90. Triozzi, PL; Stevens, VC
      Human chorionic gonadotropin as a target for cancer vaccines (Review)

      ONCOLOGY REPORTS
    91. Schirrmacher, V
      In situ analysis of tumor-specific CTL effector and memory responses elicited by tumor vaccination

      INTERNATIONAL JOURNAL OF ONCOLOGY
    92. Schirrmacher, V; Jurianz, K; Roth, C; Griesbach, A; Bonifer, R; Zawatzky, R
      Tumor stimulator cell modification by infection with Newcastle Disease Virus: Analysis of effects and mechanism in MLTC-CML cultures

      INTERNATIONAL JOURNAL OF ONCOLOGY
    93. Ben-Efraim, S
      One hundred years of cancer immunotherapy: A critical appraisal

      TUMOR BIOLOGY
    94. Rodolfo, M; Zilocchi, C; Cappetti, B; Parmiani, G; Melani, C; Colombo, MP
      Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine

      GENE THERAPY
    95. Schirrmacher, V; Haas, C; Bonifer, R; Ahlert, T; Gerhards, R; Ertel, C
      Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

      GENE THERAPY
    96. Harris, JR; Markl, J
      Keyhole limpet hemocyanin (KLH): a biomedical review

      MICRON
    97. Sun, YS; Paschen, A; Schadendorf, D
      Cells-based vaccination against melanoma - background, preliminary results, and perspective

      JOURNAL OF MOLECULAR MEDICINE-JMM
    98. Haas, C; Herold-Mende, C; Gerhards, R; Schirrmacher, V
      An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

      CANCER GENE THERAPY
    99. Taylor-Papadimitriou, J; Burchell, J; Miles, DW; Dalziel, M
      MUC1 and cancer

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    100. Herlyn, D; Birebent, B
      Advances in cancer vaccine development

      ANNALS OF MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 18:04:41